VC-Backed Cytochroma Acquired by OPKO Health
Cytochroma, Inc., a pharmaceuticals company engaged in the development and commercialization of products to treat and prevent the consequences of illnesses related to vitamin D deficiency, will be acquired by OPKO Health, Inc. for an undisclosed amount. Markham, Ontario's Cytochroma has a history of venture capital investment dating back to its seed financing in 1997. Backers have included BDC Venture Capital, Caisse de dépôt et placement du Québec, GeneChem, GrowthWorks, Mitsubishi Tanabe Pharma Corp., Novo A/S, T2C2 Capital, VenGrowth Private Equity Partners and VentureLink.
10 January 2013•5 mins read
